A language invented in the 19th century, and meant to be universal, it never really caught on. So why does a group of Esperantists from around the world gather once a year to celebrate their bond?
Hari Kondabolu (comedian and host of Politically ReActive) is our special guest co-host, with Sean Rameswaram (Radiolab Presents: More Perfect) as real-time fact-checker. Tell Me Something I Don't Know reaches into our “grab bag” for fascinating facts on the downside of keeping secrets, the origin of fantasy sports, what pronunciations say about our politics, and more.
We explore votes for English, Indonesian, and … Esperanto! The search for a common language goes back millennia, but so much still gets lost in translation. Will technology finally solve that?
Every year I post my picks for the Kentucky Derby. Last year I actually did well, for a change. In a twenty-horse field, I picked three horses to do well, and two of them ended finishing first and second. The winner was 15-1. I also made a correct prediction as to which horse would finish last. I got...
Alexandra Petri (Washington Post columnist) is our special guest co-host, with AJ Jacobs (author of It's All Relative) as real-time fact-checker. TMSIDK covers everything from birth to earth, including pregnancy tests, parenting, monogamy, aging better, and, finally, embalming.
There are 7,000 languages spoken on Earth. What are the costs — and benefits — of our modern-day Tower of Babel?
Alex Guarnaschelli, Alexandra Petri, Hari Kondabolu, Mary Roach, and Jemele Hill are some of the brilliant co-hosts joining us during Season 4. Here's a sneak peek of what you'll learn in 10 new episodes beginning September 17th.
John Urschel was the only player in the N.F.L. simultaneously getting a math Ph.D. at M.I.T. But after a new study came out linking football to brain damage, he abruptly retired. Here’s the inside story — and a look at how we make decisions in the face of risk versus uncertainty.
By some estimates, medical error is the third-leading cause of death in the U.S. How can that be? And what's to be done? Our third and final episode in this series offers some encouraging answers.
How do so many ineffective and even dangerous drugs make it to market? One reason is that clinical trials are often run on “dream patients” who aren’t representative of a larger population. On the other hand, sometimes the only thing worse than being excluded from a drug trial is being included.
We tend to think of medicine as a science, but for most of human history it has been scientific-ish at best. In the first episode of a three-part series, we look at the grotesque mistakes produced by centuries of trial-and-error, and ask whether the new era of evidence-based medicine is the solution.
Standing in line represents a particularly sloppy — and frustrating — way for supply and demand to meet. Why haven't we found a better way to get what we want? Is it possible that we secretly enjoy waiting in line? And might it even be (gulp) good for us?